|
|
|
|
|
 |
|
|

|
| Fibromyalgia Syndrome: Science or Somatic? |
| Including proceedings from a national symposium series |
| Activity Date: December 2009 — Activity Info: Volume 9, (4) |
 |
| |
Full Disclosure Policy Affecting CME Activities:
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of The Johns Hopkins University School of Medicine to require the disclosure of the existence of any relevant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Course Director and Participating Faculty reported the following:
COURSE DIRECTOR
Steven P. Cohen, MD
Associate Professor of Anesthesiology
Director of Medical Education for Pain Management Division
Johns Hopkins University School of Medicine
Baltimore, Maryland
Director of Chronic Pain Research
Walter Reed Army Medical Center
Washington, DC
Dr Cohen reports having no relationships with commercial interests related to this activity.
PARTICIPATING FACULTY
Daniel Clauw, MD
Professor of Anesthesiology and Medicine
Division of Rheumatology
University of Michigan Medical Center
Ann Arbor, Michigan
Dr Clauw reports serving as the principal investigator on grants from Forest Laboratories and Pfizer Inc; and serving as a consultant for AstraZeneca, Eli Lilly and Company, Pierre Fabre, and UCB, Inc.
Howard Smith, MD
Associate Professor of Anesthesiology,
Internal Medicine, and Physical
Rehabilitation and Medicine
Academic Director of Pain Management
Albany Medical College
Albany, New York
Dr Smith reports serving on the speakers’ bureau for Cypress Pharmaceutical, Inc and Forest Laboratories.
Off-Label Product Discussion: The audience is advised that an article in this CME activity contains reference(s) to unlabeled or unapproved uses of drugs or devices.
Dr Clauw—g-hydroxybutyrate, selective serotonin reuptake inhibitors, and tricyclic antidepressants.
All other faculty have indicated that they have not referenced unlabeled/unapproved uses of drugs or devices.
Note: Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s). |
|
|
| |
|
|
|
|
|
|
|
|
|
|